NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 77 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10 | -99.9% | 21,188 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -7.1% | 21,188 | +175.4% | 0.00% | – |
| Q1 2022 | $14,000 | -87.5% | 7,693 | -67.1% | 0.00% | – |
| Q4 2021 | $112,000 | -57.9% | 23,405 | +46.0% | 0.00% | -100.0% |
| Q2 2020 | $266,000 | -91.6% | 16,033 | -94.2% | 0.00% | -94.4% |
| Q1 2020 | $3,160,000 | -46.3% | 277,633 | -41.9% | 0.02% | -33.3% |
| Q4 2019 | $5,885,000 | +238.6% | 477,740 | -21.6% | 0.03% | +285.7% |
| Q3 2019 | $1,738,000 | – | 609,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |